Back to Search Start Over

Management of Steroid-Induced Glaucoma in a Patient with Pyoderma Gangrenosum.

Authors :
Byun JY
Kang YK
Jang YH
Kim YK
Kim DW
Source :
Journal of clinical medicine [J Clin Med] 2023 Apr 18; Vol. 12 (8). Date of Electronic Publication: 2023 Apr 18.
Publication Year :
2023

Abstract

Pyoderma gangrenosum (PG) is an uncommon inflammatory skin disorder typically presenting as painful skin ulcers, which may also exhibit extracutaneous findings. PG can occur at the site of trauma or surgery, which is known as the pathergic phenomenon. A 36-year-old man developed bilateral steroid-induced glaucoma after prolonged systemic immunosuppressive treatment for cutaneous pyoderma gangrenosum. After successful Ahmed glaucoma valve implantation surgery with donor scleral patch graft in the right eye, the same surgery failed repeatedly in the left eye and complicated with the prolonged conjunctival necrosis and the exposure of the donor scleral patch graft. Under the impression of ocular involvement of PG, microinvasive glaucoma surgery (MIGS) with XEN <superscript>®</superscript> Gel Stent was performed in the left eye; the conjunctival bleb was successfully formed without conjunctival necrosis, and intraocular pressure was well maintained. Ophthalmic surgery can be complicated in patients with PG, and the surgical option should be selected prudently to minimize surgical trauma. MIGS, as a minimally invasive surgical technique, could offer an advantage for patients with PG.

Details

Language :
English
ISSN :
2077-0383
Volume :
12
Issue :
8
Database :
MEDLINE
Journal :
Journal of clinical medicine
Publication Type :
Report
Accession number :
37109266
Full Text :
https://doi.org/10.3390/jcm12082930